196 related articles for article (PubMed ID: 8449939)
21. Cholesterol depletion disrupts caveolae and insulin receptor signaling for metabolic control via insulin receptor substrate-1, but not for mitogen-activated protein kinase control.
Parpal S; Karlsson M; Thorn H; Strålfors P
J Biol Chem; 2001 Mar; 276(13):9670-8. PubMed ID: 11121405
[TBL] [Abstract][Full Text] [Related]
22. The Shc adaptor protein is highly phosphorylated at conserved, twin tyrosine residues (Y239/240) that mediate protein-protein interactions.
van der Geer P; Wiley S; Gish GD; Pawson T
Curr Biol; 1996 Nov; 6(11):1435-44. PubMed ID: 8939605
[TBL] [Abstract][Full Text] [Related]
23. Pertussis toxin-sensitive and insensitive intracellular signalling pathways in undifferentiated 3T3-L1 cells stimulated by insulin converge with phosphatidylinositol 3-kinase upstream of the Ras mitogen-activated protein kinase cascade.
Uehara T; Tokumitsu Y; Nomura Y
Eur J Biochem; 1999 Feb; 259(3):801-8. PubMed ID: 10092867
[TBL] [Abstract][Full Text] [Related]
24. Insulin receptor substrate 2 and Shc play different roles in insulin-like growth factor I signaling.
Kim B; Cheng HL; Margolis B; Feldman EL
J Biol Chem; 1998 Dec; 273(51):34543-50. PubMed ID: 9852124
[TBL] [Abstract][Full Text] [Related]
25. Adaptor protein Shc undergoes translocation and mediates up-regulation of the tyrosine kinase c-Src in EGF-stimulated A431 cells.
Sato K; Kimoto M; Kakumoto M; Horiuchi D; Iwasaki T; Tokmakov AA; Fukami Y
Genes Cells; 2000 Sep; 5(9):749-64. PubMed ID: 10971656
[TBL] [Abstract][Full Text] [Related]
26. Relative involvement of Shc tyrosine 239/240 and tyrosine 317 on insulin induced mitogenic signaling in rat1 fibroblasts expressing insulin receptors.
Ishihara H; Sasaoka T; Wada T; Ishiki M; Haruta T; Usui I; Iwata M; Takano A; Uno T; Ueno E; Kobayashi M
Biochem Biophys Res Commun; 1998 Nov; 252(1):139-44. PubMed ID: 9813159
[TBL] [Abstract][Full Text] [Related]
27. Plasma membrane phospholipid scramblase 1 promotes EGF-dependent activation of c-Src through the epidermal growth factor receptor.
Nanjundan M; Sun J; Zhao J; Zhou Q; Sims PJ; Wiedmer T
J Biol Chem; 2003 Sep; 278(39):37413-8. PubMed ID: 12871937
[TBL] [Abstract][Full Text] [Related]
28. Cellular effects of phosphotyrosine-binding domain inhibitors on insulin receptor signaling and trafficking.
Giorgetti-Peraldi S; Ottinger E; Wolf G; Ye B; Burke TR; Shoelson SE
Mol Cell Biol; 1997 Mar; 17(3):1180-8. PubMed ID: 9032245
[TBL] [Abstract][Full Text] [Related]
29. A comparison of epidermal growth factor receptor-mediated mitogenic signaling in response to transforming growth factor alpha and epidermal growth factor in cultured fetal rat hepatocytes.
Lipeski LE; Boylan JM; Gruppuso PA
Biochem Mol Biol Int; 1996 Aug; 39(5):975-83. PubMed ID: 8866014
[TBL] [Abstract][Full Text] [Related]
30. Involvement of ErbB2 in the signaling pathway leading to cell cycle progression from a truncated epidermal growth factor receptor lacking the C-terminal autophosphorylation sites.
Sasaoka T; Langlois WJ; Bai F; Rose DW; Leitner JW; Decker SJ; Saltiel A; Gill GN; Kobayashi M; Draznin B; Olefsky JM
J Biol Chem; 1996 Apr; 271(14):8338-44. PubMed ID: 8626530
[TBL] [Abstract][Full Text] [Related]
31. Modulation of insulin-like growth factor I mitogenic signaling in 3T3-L1 preadipocyte differentiation.
Boney CM; Smith RM; Gruppuso PA
Endocrinology; 1998 Apr; 139(4):1638-44. PubMed ID: 9528944
[TBL] [Abstract][Full Text] [Related]
32. Involvement of Src-homology/collagen (SHC) proteins in signaling through the insulin receptor and the insulin-like-growth-factor-I-receptor.
Giorgetti S; Pelicci PG; Pelicci G; Van Obberghen E
Eur J Biochem; 1994 Jul; 223(1):195-202. PubMed ID: 8033892
[TBL] [Abstract][Full Text] [Related]
33. Differential utilization of ShcA tyrosine residues and functional domains in the transduction of epidermal growth factor-induced mitogen-activated protein kinase activation in 293T cells and nerve growth factor-induced neurite outgrowth in PC12 cells. Identification of a new Grb2.Sos1 binding site.
Thomas D; Bradshaw RA
J Biol Chem; 1997 Aug; 272(35):22293-9. PubMed ID: 9268379
[TBL] [Abstract][Full Text] [Related]
34. Shc products are substrates of erbB-2 kinase.
Segatto O; Pelicci G; Giuli S; Digiesi G; Di Fiore PP; McGlade J; Pawson T; Pelicci PG
Oncogene; 1993 Aug; 8(8):2105-12. PubMed ID: 8101647
[TBL] [Abstract][Full Text] [Related]
35. Direct interaction between Shc and the platelet-derived growth factor beta-receptor.
Yokote K; Mori S; Hansen K; McGlade J; Pawson T; Heldin CH; Claesson-Welsh L
J Biol Chem; 1994 May; 269(21):15337-43. PubMed ID: 8195171
[TBL] [Abstract][Full Text] [Related]
36. Shc adaptor proteins are key transducers of mitogenic signaling mediated by the G protein-coupled thrombin receptor.
Chen Y; Grall D; Salcini AE; Pelicci PG; Pouysségur J; Van Obberghen-Schilling E
EMBO J; 1996 Mar; 15(5):1037-44. PubMed ID: 8605873
[TBL] [Abstract][Full Text] [Related]
37. Hyperosmotic stress activates the insulin receptor in CHO cells.
Ouwens DM; Gomes de Mesquita DS; Dekker J; Maassen JA
Biochim Biophys Acta; 2001 Aug; 1540(2):97-106. PubMed ID: 11513972
[TBL] [Abstract][Full Text] [Related]
38. Shc and CEACAM1 interact to regulate the mitogenic action of insulin.
Poy MN; Ruch RJ; Fernstrom MA; Okabayashi Y; Najjar SM
J Biol Chem; 2002 Jan; 277(2):1076-84. PubMed ID: 11694516
[TBL] [Abstract][Full Text] [Related]
39. Epidermal growth factor receptor and the adaptor protein p52Shc are specific substrates of T-cell protein tyrosine phosphatase.
Tiganis T; Bennett AM; Ravichandran KS; Tonks NK
Mol Cell Biol; 1998 Mar; 18(3):1622-34. PubMed ID: 9488479
[TBL] [Abstract][Full Text] [Related]
40. Shc regulates epidermal growth factor-induced activation of the JNK signaling pathway.
Hashimoto A; Kurosaki M; Gotoh N; Shibuya M; Kurosaki T
J Biol Chem; 1999 Jul; 274(29):20139-43. PubMed ID: 10400627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
